Mark Sabag was appointed Executive Vice President, International Markets Commercial in 2021, leading Teva's business activities in a region comprising 27 markets, including Latin American countries, Russia and Eastern Europe, Israel, Middle East and Africa, Asia-Pacific, China and Japan.

Headquartered in Israel, Teva International Markets provides access to a high-quality portfolio of innovative medicines, affordable generics and biopharmaceuticals, active pharmaceutical ingredients (API) and over-the-counter (OTC) products and employs over 3,000 employees.

Prior to his current role and since 2013, Mark served as Executive Vice President, Chief Human Resources Officer and Head of Global Communication, Brand and ESG. Leading up to that, Mark held a variety of leadership roles in corporate global functions and commercial business units with a focus on business transformation and M&As

Before joining Teva in 2006, he held several senior global roles at Intel Corporation.

On behalf of Teva, Mark serves as a Board Member in Teva-Takeda BV in Japan and Teva-Handok JV in South Korea. He is also Co-Chair of Sanara Ventures in Israel.

Mark received a B.A. in economics and business management from Haifa University and graduated from Harvard Business School Advanced Management Program in 2021.